SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jubilant Life Sciences' arm to receive $147.5 million financing package from IFC

27 May 2014 Evaluate

Jubilant Life Sciences - wholly owned subsidiary - Jubilant Pharma, will be receiving financing package from IFC, a member of the World Bank Group.  IFC is lending $147.5 million to Jubilant Pharma to enable better access to quality and affordable pharmaceuticals in underserved markets in India and across the world. Jubilant Pharma is incorporated in Singapore, with manufacturing operations in India, USA, and Canada.

Of the total financing package, $110 million is from IFC’s own account. The remaining $37.5 million is from IFC’s Managed Co-Lending Portfolio Program, which provides additional long-term financing through co-financing partners. The loan will help Jubilant Life Sciences increase focus on the pharmaceutical sector and strengthen its generic drug manufacturing facilities in India.

Jubilant Life Sciences is a pharmaceutical and life sciences company engaged in the manufacture and supply of active pharmaceutical ingredients, generics, specialty pharmaceuticals, and life science ingredients. It provides services in contract manufacturing and drug discovery and development.

Jubilant Pharmova Share Price

910.00 5.60 (0.62%)
21-Apr-2026 12:27 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1670.00
Dr. Reddys Lab 1221.00
Cipla 1232.00
Zydus Lifesciences 927.00
Lupin 2321.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×